innovax-ilt
intervet international b.v. - celični živčni rekombinantni herpesvirus puranov (sev hvt / ilt-138), izražanje glikoproteinov gd in gi virusa infekcijskega laringotraheitisa - immunologicals za aves, Živo virusna cepiva - piščanec - za aktivno imunizacijo enodnevnih piščancev za zmanjšanje smrtnosti, kliničnih znakov in lezij zaradi okužbe z virusom kužnih laringotracheitisa (avt) in virusom marekove bolezni (md).
innovax-nd-ilt
intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - imunologija za aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.
kinpeygo
stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - antidiarrheals, črevesne protivnetna / antiinfective agenti - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1. 5 g/gram.
primovist 0,25 mmol/ml raztopina za injiciranje v napolnjeni injekcijski brizgi
bayer d.o.o. - dinatrijeva sol gadoksetne kisline - raztopina za injiciranje v napolnjeni injekcijski brizgi - dinatrijeva sol gadoksetne kisline 181,43 mg / 1 ml - gadoksetinska kislina
primovist 0,25 mmol/ml raztopina za injiciranje v napolnjeni injekcijski brizgi
bayer d.o.o. - dinatrijeva sol gadoksetne kisline - raztopina za injiciranje v napolnjeni injekcijski brizgi - dinatrijeva sol gadoksetne kisline 181,43 mg / 1 ml - gadoksetinska kislina
kesimpta
novartis ireland ltd - ofatumumab - multiplo sklerozo, recidivno-nakazila - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.
efigalo 0,5 mg trde kapsule
fingolimod - kapsula, trda - fingolimod 0,5 mg / 1 kapsula - fingolimod
efigalo 0,5 mg trde kapsule
fingolimod - kapsula, trda - fingolimod 0,5 mg / 1 kapsula - fingolimod
efigalo 0,5 mg trde kapsule
fingolimod - kapsula, trda - fingolimod 0,5 mg / 1 kapsula - fingolimod
efigalo 0,5 mg trde kapsule
fingolimod - kapsula, trda - fingolimod 0,5 mg / 1 kapsula - fingolimod